Vise Technologies’s Idexx Laboratories IDXX Stock Holding History

Vise Technologies’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$810K	Hold	1,197	–	–	0.02%	663
2025 Q4	$810K	Buy	1,197 +258	+27%	+$176K	0.02%	668
2025 Q3	$600K	Buy	939 +12	+1%	+$7.28K	0.02%	590
2025 Q2	$497K	Buy	+927	New	+$443K	0.02%	644
2024 Q4	$262K	Buy	633 +107	+20%	+$46.9K	0.02%	652
2024 Q3	$266K	Buy	+526	New	+$256K	0.03%	485

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vise Technologies's IDXX Position: Q1 2026 in Review

Vise Technologies held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 1,197 shares worth $810K. The position accounts for 0.02% of the portfolio, ranked #663.

Vise Technologies first reported a position in IDXX in Q3 2024 and has held it in 6 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Vise Technologies held 1,197 shares of Idexx Laboratories worth $810K as of Q1 2026.
Vise Technologies left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up 0.02% of Vise Technologies's portfolio in Q1 2026, its #663 holding.
Vise Technologies first reported a position in Idexx Laboratories in Q3 2024 and has held it in 6 quarters since.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.